3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
 
MMTC15_Header  
MMTC M Header 

Cambridge Healthtech Institute’s Eighth Annual

Cancer Molecular Markers

Guiding Cancer Management

February 16-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference

 

Scientific Advisory Board

Stefanie Jeffrey, M.D., John and Marva Warnock Professor, Surgery; Chief, Surgical Oncology Research, Stanford University School of Medicine
Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University, Medical Center Hamburg-Eppendorf, University of Hamburg
Steven A. Soper, Ph.D., William H. Pryor Emeritus Professor, Biomedical Engineering and Chemistry, University of North Carolina, Chapel Hill
Avraham Rasooly, Ph.D., Health Scientist Administrator, Cancer Diagnosis Program, National Cancer Institute


KEYNOTE SESSION: MARKER OF CHOICE FOR CLINICAL USE

CTC: Current Clinical Utility and Future Prospects

Daniel F. Hayes, M.D., F.A.S.C.O., Stuart B. Padnos Professor, Breast Cancer Research; Clinical Director, Breast Oncology Program, Internal Medicine and Hematology Oncology, University of Michigan Comprehensive Cancer Center

Talk Title to be Announced

Daniel Danila, M.D., Medical Oncology Fellow, Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering


CHARACTERIZING CTCs

Circulating Tumor Cells in Lung Cancer, Biomarkers, Biology, and Mouse Models

Caroline Dive, BPharm, Ph.D., Professor & Senior Group Leader, Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute

Novel Approaches to Enable Molecular Characterization of CTCs

Nikolas H. Stoecklein, M.D., Professor, General Visceral, and Pediatric Surgery, University Hospital of the Heinrich-Heine, University of Düsseldorf

Deep Sequencing of Circulating Tumor Cells as a Window into Disseminated Cancer

Jens Lohr, M.D., Ph.D., Instructor in Medicine, Medical Oncology, Cancer Program, Dana-Farber Cancer Institute; Broad Institute


CELLS VS. CIRCULATING BIOMARKERS

Platforms for CTC Isolation and Analysis

Z. Hugh Fan, Ph.D., Professor, Mechanical and Aerospace Engineering, University of Florida

ctDNA

Jorge S. Reis-Filho, M.D., Ph.D., FRCPath, Experimental Pathologist, Pathology, Memorial Sloan Kettering

Circulating Exosomes

Raghu Kalluri, M.D., Ph.D., Professor, Cancer Biology; Chair, Cancer Biology, MD Anderson

Microfluidic Isolation of Microvesicles and Circulating Tumor Cells from Cancer Patients

Shannon L. Stott, Ph.D., Assistant Professor, Medicine, Massachusetts General Hospital and Harvard Medical School


TAKING A SNAPSHOT OF BLOOD, PLASMA AND SERUM TO LEARN ABOUT THE HEALTH OF THE PATIENT

Translating a Trillion Points of Data into Therapies, Diagnostics, and New Insights into Disease

Atul Butte, M.D., Ph.D., Division Chief and Associate Professor, Stanford University School of Medicine; Director, Center for Pediatric Bioinformatics, Lucile Packard Children’s Hospital; Co-Founder, Personalis and NuMedii

Adventitious Maternal Cancer Detection during Non-Invasive Prenatal Testing Of Circulating Fetal DNA

Juan-Sebastian Saldivar, M.D., FACMG, Vice President, Clinical Services and Medical Affairs, Sequenom Laboratories

Personalized Genomic Analyses of Human Cancer

Victor Velculescu, M.D., Ph.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Cancer Center

Innovative Targeted RNA-Seq Method for Identifying Known and Novel Gene Fusion Events in Tumor Cells

Jonathan Scolnick, Ph.D., Scientist, Research, NuGEN Technologies


DNA METHYLATION FOR CANCER DIAGNOSTICS

DNA Methylation as Cancer Biomarkers in Clinical Development

David Shames, Ph.D., Senior Scientist, Genentech

Defining the Epigenetic Landscape during Normal and Malignant Hematopoiesis

Lucy A. Godley, M.D., Ph.D., Associate Professor, Department of Medicine, Section of Hematology/Oncology, Cancer Research Center, The University of Chicago

DNA Methylation Alterations in Lung Adenocarcinoma

Ite A. Laird-Offringa, Ph.D., Director, Biomedical and Biological Sciences; Associate Professor, Surgery, Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern California


CLINICAL USE OF CTCs

New Results on CTCs in Glioma Patients and Next-Generation Sequencing Data

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf

Clinical Applications of the Genetic Variation of Circulating Tumor Cells

Sunney Xie, Ph.D., Mallinckrodt Professor, Chemistry and Chemical Biology, Harvard University

Targeting Microtentacles on Circulating Tumor Cells to Reduce Metastasis

Stuart S. Martin, Ph.D., Associate Professor, Physiology, Greenebaum Cancer Center, University of Maryland School of Medicine


UNLOCKING NEW MARKERS FOR STRATIFICATION

Orion Bionetworks, a Novel Cooperative Partnership for Systems Modeling and Biomarker Discovery for Brain Diseases

Magali Haas, M.D., Ph.D., Founder and Chief Executive Officer, Orion Bionetworks

The Impact of Tumor Heterogeneity on Clinical Biomarker Development Using FFPE Tissue

Ken Chang, Ph.D., Senior Principal Scientist, Molecular Biomarkers and Diagnostics, Merck Clinical Labs

 


  2015 Plenary Sessions 


2015 MMTC Prelim Agenda 

Premier Sponsors:

 

Elsevier 


Jackson Laboratory - small logo 

Leica Biosystems 
 

 NanoString2   

 

Singulex